Asia-Pacific Americas Africa Europe Middle East

CITI PHARM LTD

Company Profile:



Company Overview:

CITI PHARM LTD is a pharmaceutical manufacturing company based in Pakistan. Established with the aim of contributing to the healthcare sector, the company focuses on the production and distribution of a wide range of pharmaceutical products. It is recognized for its commitment to quality and affordability, adhering to industry standards in its manufacturing processes.

Nature of Business:

Manufacturer (Factory)

Industry:

Pharmaceuticals

Key Activities and Products:

CITI PHARM LTD specializes in the manufacturing of various pharmaceutical formulations. Their product portfolio typically includes:

* Tablets

* Capsules

* Syrups

* Suspensions

* Other sterile and non-sterile dosage forms

The company is dedicated to providing high-quality, effective, and accessible medicines to meet the healthcare needs of the population.

Enterprise Products

CITI PHARM LTD in Pakistan produces or sells a range of pharmaceutical products across various therapeutic categories. These commonly include:

Antibiotics: Such as Amoxicillin, Cefixime, Azithromycin, and Metronidazole.

Analgesics and Antipyretics: Including Paracetamol, Ibuprofen, and Diclofenac.

Gastrointestinal Products: Like Omeprazole, Ranitidine, and Domperidone.

Vitamins and Nutritional Supplements: Such as Multivitamins and Vitamin C.

Antihistamines: For example, Cetirizine and Loratadine.

Cough and Cold Preparations: Including various syrups and expectorants.

Cardiovascular Medicines: Such as Amlodipine and Losartan.

Anti-diabetic Drugs: Like Metformin.

Anti-fungal Medications.

Anti-ulcerants.

Anti-allergics.

Anti-spasmodics.

Dermatological preparations.

Business Registration Information:

Manager:

Muhammad Yasir (CEO)

Phone:

+92-42-35925001-4

E-mail:

info@citipharma.com.pk

Official Website:
Address:

15-KM, Ferozepur Road, Lahore, Pakistan

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.